Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The 4 mg dose produced 11% weight loss, still clinically meaningful but notably lower than the maximum dose
In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease
I ordered Semaglutide and was impressed by how quickly it arrived
In skincare, it is mostly a humectant and skin conditioning agent
The observed clinical benefits appear to stem primarily from weight loss rather than direct analgesic mechanisms
Do not make any changes to your dose without consulting a healthcare provider
